Krystal, A., Pizzagalli, D., Smoski, M., Mathew, S., Nurnberger, J., Lisanby, S., … Potter, W. (2019). 116. Results of the NIMH FAST-MAS Phase IIa Proof of Mechanism Study of the Effects of the Selective κ Opioid Antagonist JNJ-67953964 on fMRI Ventral Striatal Activity in Anhedonic Patients. In Biological Psychiatry (Vol. 85, pp. S48–S49). Elsevier BV. https://doi.org/10.1016/j.biopsych.2019.03.130

Krystal, Andrew, Diego Pizzagalli, Moria Smoski, Sanjay Mathew, John Nurnberger, Sarah Lisanby, Dan Iosifescu, et al. “116. Results of the NIMH FAST-MAS Phase IIa Proof of Mechanism Study of the Effects of the Selective κ Opioid Antagonist JNJ-67953964 on fMRI Ventral Striatal Activity in Anhedonic Patients.” In Biological Psychiatry, 85:S48–49. Elsevier BV, 2019. https://doi.org/10.1016/j.biopsych.2019.03.130.

Krystal A, Pizzagalli D, Smoski M, Mathew S, Nurnberger J, Lisanby S, et al. 116. Results of the NIMH FAST-MAS Phase IIa Proof of Mechanism Study of the Effects of the Selective κ Opioid Antagonist JNJ-67953964 on fMRI Ventral Striatal Activity in Anhedonic Patients. In: Biological Psychiatry. Elsevier BV; 2019. p. S48–9.

Krystal, Andrew, et al. “116. Results of the NIMH FAST-MAS Phase IIa Proof of Mechanism Study of the Effects of the Selective κ Opioid Antagonist JNJ-67953964 on fMRI Ventral Striatal Activity in Anhedonic Patients.” Biological Psychiatry, vol. 85, no. 10, Elsevier BV, 2019, pp. S48–49. Crossref, doi:10.1016/j.biopsych.2019.03.130.

Krystal A, Pizzagalli D, Smoski M, Mathew S, Nurnberger J, Lisanby S, Iosifescu D, Murrough J, Weiner R, Calabrese J, Sanacora G, Keefe R, Song A, Goodman W, Szabo S, Whitten A, Gao K, Potter W. 116. Results of the NIMH FAST-MAS Phase IIa Proof of Mechanism Study of the Effects of the Selective κ Opioid Antagonist JNJ-67953964 on fMRI Ventral Striatal Activity in Anhedonic Patients. Biological Psychiatry. Elsevier BV; 2019. p. S48–S49.